Reports for ARALEZ PHARMACEUTICALS CANADA INC

Company Name

ARALEZ PHARMACEUTICALS CANADA INC

Totals

Shortage reports

6

Actual shortage: 0 (0%)
Anticipated shortage: 0 (0%)
Avoided shortage: 0 (0%)
Resolved: 6 (100%)

Discontinuation Reports

1

To be discontinued: 0 (0%)
Discontinued: 1 (100%)
Reversed: 0 (0%)

Late reports

0 (0%)

Overdue reports

0 (0%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
FIORINAL-C 1/2 330MG 40MG 30MG 50MG CAPSULE Resolved 2020-06-16 2020-10-01 117997
FIORINAL-C 1/4 330MG 50MG 15MG 40MG CAPSULE Resolved 2020-01-09 2020-10-22 102895
FIORINAL-C 1/4 15MG 50MG 40MG 330MG CAPSULE Resolved 2023-08-30 2023-10-06 203315
MOVIPREP 4.7G 5.9G 1.015G 2.691G 7.5G 100G POWDER FOR SOLUTION Resolved 2022-08-10 2022-10-01 166431
PEGALAX 100% POWDER FOR SOLUTION Resolved 2022-02-18 2022-03-10 155275
PEGALAX 100% POWDER FOR SOLUTION Resolved 2022-08-01 2022-09-26 165841

Showing 1 to 6 of 6

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
PEGALAX 100% POWDER FOR SOLUTION Discontinued 2023-08-01 2023-08-02 200635

Showing 1 to 1 of 1